• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自老年2型糖尿病患者的重编程角质形成细胞可抑制衰老基因以获得诱导多能性。

Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency.

作者信息

Ohmine Seiga, Squillace Karen A, Hartjes Katherine A, Deeds Michael C, Armstrong Adam S, Thatava Tayaramma, Sakuma Toshie, Terzic Andre, Kudva Yogish, Ikeda Yasuhiro

机构信息

Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Aging (Albany NY). 2012 Jan;4(1):60-73. doi: 10.18632/aging.100428.

DOI:10.18632/aging.100428
PMID:22308265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3292906/
Abstract

Nuclear reprogramming enables patient-specific derivation of induced pluripotent stem (iPS) cells from adult tissue. Yet, iPS generation from patients with type 2 diabetes (T2D) has not been demonstrated. Here, we report reproducible iPS derivation of epidermal keratinocytes (HK) from elderly T2D patients. Transduced with human OCT4, SOX2, KLF4 and c-MYC stemness factors under serum-free and feeder-free conditions, reprogrammed cells underwent dedifferentiation with mitochondrial restructuring, induction of endogenous pluripotency genes - including NANOG, LIN28, and TERT, and down-regulation of cytoskeletal, MHC class I- and apoptosis-related genes. Notably, derived iPS clones acquired a rejuvenated state, characterized by elongated telomeres and suppressed senescence-related p15INK4b/p16INK4a gene expression and oxidative stress signaling. Stepwise guidance with lineage-specifying factors, including Indolactam V and GLP-1, redifferentiated HK-derived iPS clones into insulin-producing islet-like progeny. Thus, in elderly T2D patients, reprogramming of keratinocytes ensures a senescence-privileged status yielding iPS cells proficient for regenerative applications.

摘要

核重编程能够从成体组织中获得患者特异性的诱导多能干细胞(iPS细胞)。然而,尚未证实能够从2型糖尿病(T2D)患者中生成iPS细胞。在此,我们报告了从老年T2D患者的表皮角质形成细胞(HK)中可重复地获得iPS细胞。在无血清和无饲养层条件下,用人OCT4、SOX2、KLF4和c-MYC干性因子进行转导,重编程细胞经历去分化,伴有线粒体重塑、内源性多能性基因(包括NANOG、LIN28和TERT)的诱导,以及细胞骨架、MHC I类和凋亡相关基因的下调。值得注意的是,所获得的iPS克隆进入了年轻化状态,其特征为端粒延长、衰老相关的p15INK4b/p16INK4a基因表达受到抑制以及氧化应激信号传导被抑制。使用包括吲哚内酰胺V和胰高血糖素样肽-1在内的谱系特异性因子进行逐步引导,可将源自HK的iPS克隆重新分化为产生胰岛素的胰岛样后代。因此,在老年T2D患者中,角质形成细胞的重编程确保了一种衰老特权状态,从而产生适用于再生应用的iPS细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/ab844ae8e2f2/aging-04-060-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/c6825b696bba/aging-04-060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/daff9be98864/aging-04-060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/deecfbab6951/aging-04-060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/c911ca1e7fe4/aging-04-060-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/f3642098941f/aging-04-060-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/ab844ae8e2f2/aging-04-060-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/c6825b696bba/aging-04-060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/daff9be98864/aging-04-060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/deecfbab6951/aging-04-060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/c911ca1e7fe4/aging-04-060-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/f3642098941f/aging-04-060-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/3292906/ab844ae8e2f2/aging-04-060-g006.jpg

相似文献

1
Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency.来自老年2型糖尿病患者的重编程角质形成细胞可抑制衰老基因以获得诱导多能性。
Aging (Albany NY). 2012 Jan;4(1):60-73. doi: 10.18632/aging.100428.
2
iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.在没有c-MYC的情况下进行编程的诱导多能干细胞可实现高效的心脏发生,用于功能性心脏嵌合体。
Circ Res. 2009 Sep 25;105(7):648-56. doi: 10.1161/CIRCRESAHA.109.203109. Epub 2009 Aug 20.
3
Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.由 GMP 级造血祖细胞和单核髓样细胞诱导的多能干细胞。
Stem Cell Res Ther. 2011 Nov 16;2(6):46. doi: 10.1186/scrt87.
4
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.从人角质形成细胞高效快速地生成诱导多能干细胞。
Nat Biotechnol. 2008 Nov;26(11):1276-84. doi: 10.1038/nbt.1503. Epub 2008 Oct 17.
5
Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny.吲哚拉明 V/GLP-1 介导的人诱导多能干细胞向葡萄糖反应性胰岛素分泌祖细胞的分化。
Gene Ther. 2011 Mar;18(3):283-93. doi: 10.1038/gt.2010.145. Epub 2010 Nov 4.
6
Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.诱导雪豹(Panthera uncia)体细胞的多能性,雪豹是一种濒危猫科动物。
Theriogenology. 2012 Jan 1;77(1):220-8, 228.e1-2. doi: 10.1016/j.theriogenology.2011.09.022. Epub 2011 Nov 11.
7
Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.1 型和 2 型糖尿病患者的无转基因疾病特异性诱导多能干细胞。
Stem Cells Transl Med. 2012 Jun;1(6):451-61. doi: 10.5966/sctm.2011-0044. Epub 2012 May 30.
8
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.用于定制化胰岛再生的患者来源诱导多能干细胞后代的无瘤移植
Stem Cells Transl Med. 2016 May;5(5):694-702. doi: 10.5966/sctm.2015-0017. Epub 2016 Mar 17.
9
Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation.成功地从肾移植患者中诱导出具有疾病特异性的多能干细胞。
Stem Cell Res Ther. 2011 Dec 6;2(6):48. doi: 10.1186/scrt89.
10
c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.c-MYC 非依赖性核重编程有利于诱导多能干细胞的心脏生成潜能。
J Cardiovasc Transl Res. 2010 Feb;3(1):13-23. doi: 10.1007/s12265-009-9150-5.

引用本文的文献

1
Reconstruction of functional human epidermis equivalent containing 5%IPS-derived keratinocytes treated with mitochondrial stimulating plant extracts.重建含 5%IPS 来源角质形成细胞的功能性人表皮等效物,并用线粒体刺激植物提取物处理。
Sci Rep. 2022 May 31;12(1):9073. doi: 10.1038/s41598-022-13191-4.
2
Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes.迈向糖尿病的精准医学:人类多能干细胞的应用
Stem Cells Transl Med. 2022 Jul 20;11(7):704-714. doi: 10.1093/stcltm/szac030.
3
Manufacturing clinical-grade human induced pluripotent stem cell-derived beta cells for diabetes treatment.

本文引用的文献

1
Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.体细胞氧化生物能学转变为依赖多能性的糖酵解,以促进核重编程。
Cell Metab. 2011 Aug 3;14(2):264-71. doi: 10.1016/j.cmet.2011.06.011.
2
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.生成仅在两个早发性帕金森病点突变处存在差异的同基因多能干细胞。
Cell. 2011 Jul 22;146(2):318-31. doi: 10.1016/j.cell.2011.06.019. Epub 2011 Jul 14.
3
Chronic diseases: the emerging pandemic.
用于糖尿病治疗的临床级人诱导多能干细胞衍生β细胞的制造。
Cell Prolif. 2022 Aug;55(8):e13232. doi: 10.1111/cpr.13232. Epub 2022 Apr 26.
4
"Ryanopathies" and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?“Ryanopathies”和 RyR2 功能障碍:我们能否使用体外人类疾病模型进一步解析它们?
Cell Death Dis. 2021 Nov 1;12(11):1041. doi: 10.1038/s41419-021-04337-9.
5
Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.诱导多能干细胞生成β细胞作为治疗糖尿病的潜在方法:最新进展。
Adv Exp Med Biol. 2021;1347:1-27. doi: 10.1007/5584_2021_653.
6
GATA6 regulates aging of human mesenchymal stem/stromal cells.GATA6 调控人间质干细胞/基质细胞衰老。
Stem Cells. 2021 Jan;39(1):62-77. doi: 10.1002/stem.3297. Epub 2020 Nov 30.
7
Modeling different types of diabetes using human pluripotent stem cells.使用人类多能干细胞建模不同类型的糖尿病。
Cell Mol Life Sci. 2021 Mar;78(6):2459-2483. doi: 10.1007/s00018-020-03710-9. Epub 2020 Nov 26.
8
Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes.诱导多能干细胞衍生的胰岛素/葡萄糖反应细胞:糖尿病的疾病建模和治疗。
Cells. 2020 Nov 12;9(11):2465. doi: 10.3390/cells9112465.
9
Models of Neurodegenerative Diseases.神经退行性疾病模型
Front Cell Dev Biol. 2020 May 13;8:328. doi: 10.3389/fcell.2020.00328. eCollection 2020.
10
Engineering pancreatic tissues from stem cells towards therapy.利用干细胞构建胰腺组织用于治疗。
Regen Ther. 2016 Mar 1;3:15-23. doi: 10.1016/j.reth.2016.01.002. eCollection 2016 Mar.
慢性病:新出现的大流行病。
Clin Transl Sci. 2011 Jun;4(3):225-6. doi: 10.1111/j.1752-8062.2011.00295.x.
4
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease.基于蛋白质的人诱导多能干细胞能有效地生成功能性多巴胺神经元,并能治疗帕金森病大鼠模型。
J Clin Invest. 2011 Jun;121(6):2326-35. doi: 10.1172/JCI45794. Epub 2011 May 16.
5
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.从一名回旋性萎缩症患者诱导多能干细胞中进行基因矫正和分析。
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6537-42. doi: 10.1073/pnas.1103388108. Epub 2011 Apr 4.
6
iPS cells in type 1 diabetes research and treatment.诱导多能干细胞在1型糖尿病研究与治疗中的应用
Clin Pharmacol Ther. 2011 May;89(5):750-3. doi: 10.1038/clpt.2011.1. Epub 2011 Mar 23.
7
Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny.吲哚拉明 V/GLP-1 介导的人诱导多能干细胞向葡萄糖反应性胰岛素分泌祖细胞的分化。
Gene Ther. 2011 Mar;18(3):283-93. doi: 10.1038/gt.2010.145. Epub 2010 Nov 4.
8
Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells.利用种间囊胚注射多能干细胞在鼠体内生成大鼠胰腺。
Cell. 2010 Sep 3;142(5):787-99. doi: 10.1016/j.cell.2010.07.039.
9
Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells.人类胚胎干细胞和诱导多能干细胞的染色质结构和基因表达程序。
Cell Stem Cell. 2010 Aug 6;7(2):249-57. doi: 10.1016/j.stem.2010.06.015.
10
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.LEOPARD 综合征的患者特异性诱导多能干细胞衍生模型。
Nature. 2010 Jun 10;465(7299):808-12. doi: 10.1038/nature09005.